We are live on
!
Find out more
BioNTech
BNTX
BNTX
272 hedge funds and large institutions have $4.22B invested in BioNTech in 2026 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 92 increasing their positions, 74 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
24% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 74
2.36% less ownership
Funds ownership: 21.27% → 18.91% (-2.4%)
4% less funds holding
Funds holding: 284 → 272 (-12)
7% less capital invested
Capital invested by funds: $4.56B → $4.22B (-$339M)
18% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 50
56% less call options, than puts
Call options by funds: $86.1M | Put options by funds: $198M
Holders
272
Holders Change
-12
Holders Change %
-4.23%
% of All Funds
3.35%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
41
Increased
92
Reduced
74
Closed
50
Calls
$86.1M
Puts
$198M
Net Calls
-$112M
Net Calls Change
-$108M
Top Buyers
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$141M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$68.9M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$54.8M |
| 4 |
BlackRock
New York
|
+$51.9M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$46.4M |
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$108M |
| 2 |
Jane Street
New York
|
-$105M |
| 3 |
Flossbach Von Storch
Cologne,
Germany
|
-$53M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$37.2M |
| 5 |
D.E. Shaw & Co
New York
|
-$29.7M |
